WSJ -- Brainsway Ltd. unveiled estimated terms of its downsized plans for an initial public offering, as the Israeli-based medical device company looks to raise money to fund manufacturing, ongoing and future clinical trials, and research and development.
The company plans to offer a minimum of about 1.8 million shares for ...
